Search results
Results from the WOW.Com Content Network
In U.S. health insurance, a preferred provider organization (PPO), sometimes referred to as a participating provider organization or preferred provider option, is a managed care organization of medical doctors, hospitals, and other health care providers who have agreed with an insurer or a third-party administrator to provide health care at ...
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
Texas Health Resources is a faith-based non-profit health system operating in the United States in North Texas. It provides care to inpatients and outpatients across its network of facilities. It provides care to inpatients and outpatients across its network of facilities.
Five factors that can be used to assess the advancement level of a particular IDN include provider alignment, continuum of care, regional presence, clinical integration, and reimbursement. [5] Between 2013 and 2017, healthcare providers created 11 new integrated delivery systems from joint ventures with insurance companies. [6]
A January 2013 survey of 400 community pharmacists documented such instances as well as widespread confusion among patients when it comes to distinguishing between "preferred pharmacies" and "non-preferred" or "network" pharmacies. These concerns were shared by CMS in their 2015 Final Call Letter, issued on April 7, 2014. In this letter, CMS ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The difference between an opioid and an opioid agonist is that opioids induce more intense effects and stay in the brain for a short amount of time. [3] Conversely, an opioid agonist induces minimal effects and stays in the brain for a long time, which prevents the opioid user from feeling the effects of natural or synthetic opioids. [3]
The metabolic half-life is 8 to 59 hours (approximately 24 hours for opioid-tolerant people, and 55 hours for opioid-naive people), as opposed to a half-life of 1 to 5 hours for morphine. [12] The length of the half-life of methadone allows for the exhibition of respiratory depressant effects for an extended duration of time in opioid-naive people.